Found: 151
Select item for more details and to access through your institution.
The Lymphoma Epidemiology of Outcomes cohort study: Design, baseline characteristics, and early outcomes.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 3, p. 408, doi. 10.1002/ajh.27202
- By:
- Publication type:
- Article
Survival trends in young patients with Waldenström macroglobulinemia: Over five decades of experience.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 3, p. 432, doi. 10.1002/ajh.26807
- By:
- Publication type:
- Article
Clinical characteristics, prognostic indicators, and survival outcomes in intravascular lymphoma: Mayo Clinic experience (2003–2018).
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 9, p. 1150, doi. 10.1002/ajh.26635
- By:
- Publication type:
- Article
Anthracycline treatment, cardiovascular risk factors and the cumulative incidence of cardiovascular disease in a cohort of newly diagnosed lymphoma patients from the modern treatment era.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 8, p. 979, doi. 10.1002/ajh.26230
- By:
- Publication type:
- Article
Assessment of fixed‐duration therapies for treatment‐naïve Waldenström macroglobulinemia.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 8, p. 945, doi. 10.1002/ajh.26210
- By:
- Publication type:
- Article
Testicular FDG‐PET/CT uptake threshold in aggressive lymphomas.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 3, p. E81, doi. 10.1002/ajh.26073
- By:
- Publication type:
- Article
Addition of venetoclax at time of progression in ibrutinib‐treated patients with chronic lymphocytic leukemia: Combination therapy to prevent ibrutinib flare.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 3, p. E57, doi. 10.1002/ajh.25690
- By:
- Publication type:
- Article
Detection of extranodal and spleen involvement by FDG‐PET imaging predicts adverse survival in untreated follicular lymphoma.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 7, p. 786, doi. 10.1002/ajh.25493
- By:
- Publication type:
- Article
Host genetic variation in tumor necrosis factor and nuclear factor‐κB pathways and overall survival in mantle cell lymphoma: A discovery and replication study.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 6, p. E153, doi. 10.1002/ajh.25451
- By:
- Publication type:
- Article
Role of systemic high‐dose methotrexate and combined approaches in the management of vitreoretinal lymphoma: A single center experience 1990‐2018.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 3, p. 291, doi. 10.1002/ajh.25350
- By:
- Publication type:
- Article
The association of physical activity before and after lymphoma diagnosis with survival outcomes.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 12, p. 1543, doi. 10.1002/ajh.25288
- By:
- Publication type:
- Article
Predictors of symptomatic hyperviscosity in Waldenström macroglobulinemia.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 11, p. 1384, doi. 10.1002/ajh.25254
- By:
- Publication type:
- Article
<italic>MYD88</italic> mutation status does not impact overall survival in Waldenström macroglobulinemia.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 2, p. 187, doi. 10.1002/ajh.24955
- By:
- Publication type:
- Article
Long-term follow-up of chemoimmunotherapy with rituximab, oxaliplatin, cytosine arabinoside, dexamethasone (ROAD) in patients with relapsed CD20+ B-cell non-Hodgkin lymphoma: Results of a study of the Mayo Clinic Cancer Center Research Consortium (MCCRC) MC0485 now known as academic and community cancer research united (ACCRU)
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 10, p. 1004, doi. 10.1002/ajh.24824
- By:
- Publication type:
- Article
Long-term analysis of phase II studies of single-agent lenalidomide in relapsed/refractory mantle cell lymphoma.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 10, p. E575, doi. 10.1002/ajh.24854
- By:
- Publication type:
- Article
Associations between elevated pre-treatment serum cytokines and peripheral blood cellular markers of immunosuppression in patients with lymphoma.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 8, p. 752, doi. 10.1002/ajh.24758
- By:
- Publication type:
- Article
Efficacy of the oral mTORC1 inhibitor everolimus in relapsed or refractory indolent lymphoma.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 5, p. 448, doi. 10.1002/ajh.24671
- By:
- Publication type:
- Article
Reduction in C-reactive protein indicates successful targeting of the IL-1/IL-6 axis resulting in improved survival in early stage multiple myeloma.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 6, p. 571, doi. 10.1002/ajh.24352
- By:
- Publication type:
- Article
Personalized risk prediction for event-free survival at 24 months in patients with diffuse large B-cell lymphoma.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 2, p. 179, doi. 10.1002/ajh.24223
- By:
- Publication type:
- Article
Elevated soluble IL-2 Rα, IL-8, and MIP-1β levels are associated with inferior outcome and are independent of MIPI score in patients with mantle cell lymphoma.
- Published in:
- American Journal of Hematology, 2014, v. 89, n. 12, p. E223, doi. 10.1002/ajh.23838
- By:
- Publication type:
- Article
Elevated monoclonal and polyclonal serum immunoglobulin free light chain as prognostic factors in B- and T-cell non- Hodgkin lymphoma.
- Published in:
- American Journal of Hematology, 2014, v. 89, n. 12, p. 1116, doi. 10.1002/ajh.23839
- By:
- Publication type:
- Article
The utility of restaging bone marrow biopsy in PET-negative patients with diffuse large B-cell lymphoma and baseline bone marrow involvement.
- Published in:
- American Journal of Hematology, 2014, v. 89, n. 9, p. 865, doi. 10.1002/ajh.23760
- By:
- Publication type:
- Article
Critical considerations on the utility of FDG-PET/CT for posttreatment restaging of the bone marrow in diffuse large B-cell lymphoma.
- Published in:
- American Journal of Hematology, 2014, v. 89, n. 9, p. 935, doi. 10.1002/ajh.23779
- By:
- Publication type:
- Article
Chemoimmunotherapy for relapsed/refractory and progressive 17p13-deleted chronic lymphocytic leukemia (CLL) combining pentostatin, alemtuzumab, and low-dose rituximab is effective and tolerable and limits loss of CD20 expression by circulating CLL cells.
- Published in:
- American Journal of Hematology, 2014, v. 89, n. 7, p. 757, doi. 10.1002/ajh.23737
- By:
- Publication type:
- Article
Elevated serum monoclonal and polyclonal free light chains and interferon inducible protein-10 predicts inferior prognosis in untreated diffuse large B-cell lymphoma.
- Published in:
- American Journal of Hematology, 2014, v. 89, n. 4, p. 417, doi. 10.1002/ajh.23658
- By:
- Publication type:
- Article
Long-term results of the phase II trial of the oral mTOR inhibitor everolimus (RAD001) in relapsed or refractory Waldenstrom Macroglobulinemia.
- Published in:
- American Journal of Hematology, 2014, v. 89, n. 3, p. 237, doi. 10.1002/ajh.23620
- By:
- Publication type:
- Article
A skin rash and what lies beneath: Paraneoplastic pemphigus, an atypical presentation of follicular cell lymphoma.
- Published in:
- American Journal of Hematology, 2013, v. 88, n. 9, p. 822, doi. 10.1002/ajh.23471
- By:
- Publication type:
- Article
A phase I trial of immunostimulatory CpG 7909 oligodeoxynucleotide and <sup>90</sup>yttrium ibritumomab tiuxetan radioimmunotherapy for relapsed B-cell non-Hodgkin lymphoma.
- Published in:
- American Journal of Hematology, 2013, v. 88, n. 7, p. 589, doi. 10.1002/ajh.23460
- By:
- Publication type:
- Article
Methemoglobinemia and hemolysis in a patient with G6PD deficiency treated with rasburicase.
- Published in:
- American Journal of Hematology, 2013, v. 88, n. 2, p. 152, doi. 10.1002/ajh.23182
- By:
- Publication type:
- Article
Elevated pretreatment serum levels of interferon-inducible protein-10 (CXCL10) predict disease relapse and prognosis in diffuse large B-cell lymphoma patients.
- Published in:
- American Journal of Hematology, 2012, v. 87, n. 9, p. 865, doi. 10.1002/ajh.23259
- By:
- Publication type:
- Article
Germline variation in complement genes and event-free survival in follicular and diffuse large B-cell lymphoma.
- Published in:
- American Journal of Hematology, 2012, v. 87, n. 9, p. 880, doi. 10.1002/ajh.23273
- By:
- Publication type:
- Article
Trends and outcomes of modern staging of solitary plasmacytoma of bone.
- Published in:
- American Journal of Hematology, 2012, v. 87, n. 7, p. 647, doi. 10.1002/ajh.23201
- By:
- Publication type:
- Article
Sorafenib, a multikinase inhibitor, is effective in vitro against non-hodgkin lymphoma and synergizes with the mTOR inhibitor rapamycin.
- Published in:
- American Journal of Hematology, 2012, v. 87, n. 3, p. 277, doi. 10.1002/ajh.22263
- By:
- Publication type:
- Article
Elevated serum free light chains are associated with inferior event free and overall survival in Hodgkin lymphoma.
- Published in:
- American Journal of Hematology, 2011, v. 86, n. 12, p. 998, doi. 10.1002/ajh.22168
- By:
- Publication type:
- Article
Lenalidomide, cyclophosphamide and dexamethasone (CRd) for newly diagnosed multiple myeloma: Results from a phase 2 trial.
- Published in:
- American Journal of Hematology, 2011, v. 86, n. 8, p. 640, doi. 10.1002/ajh.22053
- By:
- Publication type:
- Article
Long-term results of single-agent thalidomide as initial therapy for asymptomatic (smoldering or indolent) myeloma.
- Published in:
- American Journal of Hematology, 2010, v. 85, n. 10, p. 737, doi. 10.1002/ajh.21821
- By:
- Publication type:
- Article
Clarithromycin (Biaxin)-lenalidomide-low-dose dexamethasone (BiRd) versus lenalidomide-low-dose dexamethasone (Rd) for newly diagnosed myeloma.
- Published in:
- American Journal of Hematology, 2010, v. 85, n. 9, p. 664, doi. 10.1002/ajh.21777
- By:
- Publication type:
- Article
A Phase II trial of the oral mTOR inhibitor everolimus in relapsed Hodgkin lymphoma.
- Published in:
- American Journal of Hematology, 2010, v. 85, n. 5, p. 320, doi. 10.1002/ajh.21664
- By:
- Publication type:
- Article
Serum BLyS levels increase after rituximab as initial therapy in patients with follicular grade 1 non-Hodgkin lymphoma.
- Published in:
- American Journal of Hematology, 2009, v. 84, n. 2, p. 71, doi. 10.1002/ajh.21328
- By:
- Publication type:
- Article
Absolute lymphocyte count at the time of first relapse predicts survival in patients with diffuse large B-cell lymphoma.
- Published in:
- American Journal of Hematology, 2009, v. 84, n. 2, p. 93, doi. 10.1002/ajh.21337
- By:
- Publication type:
- Article
Treatment of diuretic refractory pleural effusions with bevacizumab in four patients with primary systemic amyloidosis.
- Published in:
- American Journal of Hematology, 2007, v. 82, n. 5, p. 409, doi. 10.1002/ajh.20858
- By:
- Publication type:
- Article
Initial increase in the cryoglobulin level after rituximab therapy for type II cryoglobulinemia secondary to Waldenstrm macroglobulinemia does not indicate failure of response.
- Published in:
- American Journal of Hematology, 2004, v. 77, n. 4, p. 329, doi. 10.1002/ajh.20207
- By:
- Publication type:
- Article
Cell proliferation of myeloma plasma cells: Comparison of the blood and marrow compartments.
- Published in:
- American Journal of Hematology, 2004, v. 77, n. 1, p. 7, doi. 10.1002/ajh.20125
- By:
- Publication type:
- Article
Alterations in cell proliferation and apoptosis in colon cancers with microsatellite instability.
- Published in:
- International Journal of Cancer, 2007, v. 120, n. 6, p. 1232, doi. 10.1002/ijc.22429
- By:
- Publication type:
- Article
Association of aspirin and other non-steroidal anti-inflammatory drug use with incidence of non-hodgkin lymphoma.
- Published in:
- International Journal of Cancer, 2003, v. 106, n. 5, p. 784, doi. 10.1002/ijc.11311
- By:
- Publication type:
- Article
MCIR1: A patient‐derived mantle cell lymphoma line for discovering new treatments for ibrutinib resistance.
- Published in:
- European Journal of Haematology, 2021, v. 107, n. 4, p. 458, doi. 10.1111/ejh.13682
- By:
- Publication type:
- Article
Weight-Based Dosing of Yttrium 90 Ibritumomab Tiuxetan in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma.
- Published in:
- Clinical Lymphoma & Myeloma, 2007, v. 7, n. 8, p. 514
- By:
- Publication type:
- Article
Building on the Promise of Radioimmunotherapy.
- Published in:
- Oncology (08909091), 2007, v. 21, n. 2, p. 217
- By:
- Publication type:
- Article
Methods for estimation of bone marrow plasma cell involvement in myeloma: Predictive value for response and survival in patients undergoing autologous stem cell transplantation.
- Published in:
- American Journal of Hematology, 2001, v. 68, n. 4, p. 269, doi. 10.1002/ajh.10003
- By:
- Publication type:
- Article
Phase II trial of high-dose dexamethasone for previously treated immunoglobulin light-chain amyloidosis.
- Published in:
- American Journal of Hematology, 1999, v. 61, n. 2, p. 115, doi. 10.1002/(SICI)1096-8652(199906)61:2<115::AID-AJH7>3.0.CO;2-I
- By:
- Publication type:
- Article